Hybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies
Ilya Kister, Ryan Curtin, Jinglan Pei, Katherine Perdomo, Tamar E. Bacon, Iryna Voloshyna, Joseph Kim, Ethan Tardio, Yogambigai Velmurugu, Samantha Nyovanie, Andrea Valeria Calderon, Fatoumatta Dibba, Stanzin Idga, Marie I. Samanovic, Pranil Raut, Catarina Raposo, Jessica Priest, Mark Cabatingan, Ryan C. Winger, Mark J. Mulligan, Yury Patskovsky, Gregg J. Silverman, Michelle Krogsgaard
doi: https://doi.org/10.1101/2022.06.28.22276989
Ilya Kister
1NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Ryan Curtin
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Jinglan Pei
3Genentech, Inc., South San Francisco, CA, USA
Katherine Perdomo
1NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Tamar E. Bacon
1NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Iryna Voloshyna
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Joseph Kim
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Ethan Tardio
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Yogambigai Velmurugu
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Samantha Nyovanie
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Andrea Valeria Calderon
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Fatoumatta Dibba
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Stanzin Idga
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Marie I. Samanovic
4NYU Langone Vaccine Center, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA
Pranil Raut
3Genentech, Inc., South San Francisco, CA, USA
Catarina Raposo
5F. Hoffmann-La Roche Ltd, Basel, Switzerland
Jessica Priest
3Genentech, Inc., South San Francisco, CA, USA
Mark Cabatingan
3Genentech, Inc., South San Francisco, CA, USA
Ryan C. Winger
3Genentech, Inc., South San Francisco, CA, USA
Mark J. Mulligan
4NYU Langone Vaccine Center, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA
Yury Patskovsky
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Gregg J. Silverman
6Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA
Michelle Krogsgaard
2Laura and Isaac Perlmutter Cancer Center and Department of Pathology, New York University Grossman School of Medicine, New York, NY, 10016, USA
Article usage
Posted June 28, 2022.
Hybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies
Ilya Kister, Ryan Curtin, Jinglan Pei, Katherine Perdomo, Tamar E. Bacon, Iryna Voloshyna, Joseph Kim, Ethan Tardio, Yogambigai Velmurugu, Samantha Nyovanie, Andrea Valeria Calderon, Fatoumatta Dibba, Stanzin Idga, Marie I. Samanovic, Pranil Raut, Catarina Raposo, Jessica Priest, Mark Cabatingan, Ryan C. Winger, Mark J. Mulligan, Yury Patskovsky, Gregg J. Silverman, Michelle Krogsgaard
medRxiv 2022.06.28.22276989; doi: https://doi.org/10.1101/2022.06.28.22276989
Hybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies
Ilya Kister, Ryan Curtin, Jinglan Pei, Katherine Perdomo, Tamar E. Bacon, Iryna Voloshyna, Joseph Kim, Ethan Tardio, Yogambigai Velmurugu, Samantha Nyovanie, Andrea Valeria Calderon, Fatoumatta Dibba, Stanzin Idga, Marie I. Samanovic, Pranil Raut, Catarina Raposo, Jessica Priest, Mark Cabatingan, Ryan C. Winger, Mark J. Mulligan, Yury Patskovsky, Gregg J. Silverman, Michelle Krogsgaard
medRxiv 2022.06.28.22276989; doi: https://doi.org/10.1101/2022.06.28.22276989
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2960)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12768)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4604)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2935)
- Health Policy (1069)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4383)
- Nursing (237)
- Nutrition (641)
- Oncology (2282)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1198)
- Primary Care Research (499)
- Public and Global Health (6967)
- Radiology and Imaging (1537)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)